25 March 1999
GM sheep firm in ‘novel products’ deal

PPL THERAPEUTICS, the firm that develops medicines from the milk of genetically modified sheep, has won a new deal.

The company has secured an agreement with Smith & Nephew to work on undisclosed “novel products” in orthopaedics and wound care.

PPL has secured the capacity to allow the full-scale commercial manufacture of AAT, its possible treatment for cystic fibrosis.

This follows the decision by the authorities in New Zealand to grant PPL permission to expand its flock of AAT-producing sheep from 147 to up to 10,000.